Posted by
on Dec 23rd, 2015 and filed under Trial: Immunotherapy more effective than chemo for lung cancer – UPI.com
LOS ANGELES, Dec. 22 (UPI) — The drug pembrolizumab, sold in the United States as Keytruda, was shown to be more effective against lung cancer than chemotherapy, according to a new study conducted at the University of California Los Angeles.
The drug was approved in October by the Food and Drug Administration for use with a specific group of advanced non-small cell lung cancer patients with a genetic mutation. Former President Jimmy Carter‘s cancer also was successfully treated with Keytruda.
Keytruda targets a protein expressed by immune cells that is exploited by cancer cells. By targeting the protein, the immune system can more strongly attack tumor cells.
“By continuing to refine and expand our selection of patients who stand to benefit from this type of therapy, we are profoundly changing the way that patients with this common cancer are treated,” said Dr. Edward Garon, a researcher at UCLA, in a press release. “For most patients, this now offers data showing that immunotherapy leads to superior clinical outcomes with a side effect profile that is generally favorable to our traditional therapies.”
In the study, researchers enrolled 1,034 patients between 2013 and 2015, randomly giving them one of two dosage sizes of pembrolizumab or the chemotherapy drug docetaxel. The researchers found no significant difference in overall survival between the docetaxel and a low dose of pembrolizumab, however a higher dose of the immunotherapy drug was significantly more effective than the chemotherapy.
“This treatment provides real hope of long-lasting responses while avoiding the toxicities of typical chemotherapy in a broad population of lung cancer patients,” Garon said. “We are excited that these results have identified a larger group of patients for whom in general, immunotherapy is a superior treatment option than traditional approaches.”
The study is published in The Lancet.
Related UPI Stories
Latest Headlines
Drugs approved for other conditions may have antibiotic effects 9 hours ago
CHAMPAIGN, Ill., Dec. 22 (UPI) — Researchers found a combination of drugs already approved for other uses have antibiotic effects.
White House releases plan to combat multidrug-resistant TB 10 hours ago
WASHINGTON, Dec. 22 (UPI) — The White House on Tuesday announced a plan to combat multidrug-resistant tuberculosis, which is responsible for 1.5 million annual deaths worldwide.
Low zinc levels indicate possible breast feeding problems 11 hours ago
UNIVERSITY PARK, Pa., Dec. 22 (UPI) — Low zinc levels indicate the potential for women to have trouble breastfeeding, according to a new study at Penn State University.
Study: Sudden cardiac arrest may not be so sudden 13 hours ago
LOS ANGELES, Dec. 22 (UPI) — Researchers in Oregon found sudden cardiac heart arrest may not be so sudden — warning signs are often ignored by patients.
Airway-on-a-chip may help advance COPD, asthma research 14 hours ago
NEW HAVEN, Conn., Dec. 22 (UPI) — A new airway-on-a-chip created at Harvard University could help advance research for cardiopulmonary obstructive disease and asthma, researchers said.
Panel suggests preventive statin use for adults over 40 15 hours ago
ROCKVILLE, Md., Dec. 22 (UPI) — Adults over 40 at risk for heart attack should take statin drugs as a preventive measure, a United States government panel recommended.
Florida pill mill crackdown curbed opioid drug deaths 1 day ago
BALTIMORE, Dec. 21 (UPI) — Florida’s actions in 2011 may have helped curb deaths from opioid-based medications, as well as heroin, according to a recent study.
Ketamine may help with overeating tied to depression 1 day ago
NEW HAVEN, Conn., Dec. 21 (UPI) — Researchers found in a study at Yale that low doses of ketamine reduced depression-like symptoms, stress and chronic overeating.
Hypertension-related ER visits rise 20 percent since 2006 1 day ago
NASHVILLE, Dec. 21 (UPI) — The rate of hypertension-related visits to the emergency room has gone up more than 20 percent in the last decade, according to a new study.
Study reveals genes make people susceptible to hernias 1 day ago
SAN FRANCISCO, Dec. 21 (UPI) — Researchers identified four genes they say predispose some people to abdominal hernias, which may lead to better treatment methods for the common condition.
